Hydralazine and connective tissue disorder Patient Reports February 12, 2012

Hydralazine Side Effects Report #5093095-6
Hydralazine side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 11, 2006. Female patient, 36 years of age, was diagnosed with hypertension and was treated with Hydralazine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, cardiomegaly, computerised tomogram abnormal, connective tissue disorder , delirium, diffuse alveolar damage. Hydralazine dosage: 100 MG QDAY PO. During the same period patient was treated with ATENOLOL, CLONIDINE, NIFEDIPINE, FOSINOPRIL, LEVOFLOXACIN. Patient was hospitalized. Patient died.

Hydralazine Side Effects Report #5044315-5
Hydralazine side effect was reported by a Health Professional from UNITED STATES on June 19, 2006. Female patient, 36 years of age, was diagnosed with hypertension and was treated with Hydralazine. After drug was administered, patient experienced the following side effects: arthralgia, blood creatine phosphokinase increased, blood lactate dehydrogenase abnormal, cardiomegaly, connective tissue disorder , delirium, diffuse alveolar damage, dizziness . Hydralazine dosage: 100 MG, QD,. During the same period patient was treated with ATENOLOL, CLONIDINE, NIFEDIPINE, FOSINOPRIL, LEVOFLOXACIN. Patient died.